Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Immunic, Inc. - Common Stock (NQ:IMUX)

0.5537 +0.0200 (+3.75%)
Streaming Delayed Price Updated: 1:19 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Immunic, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
This Electronic Arts Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday ↗
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings... 
Via Benzinga
News headline image
This VSE Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings... 
Via Benzinga
News headline image
Immunic (IMUX) Q2 Loss Widens 25% ↗
Via The Motley Fool
News headline image
Immunic Announces Vidofludimus Calcium Reduced Risk of Disability Worsening by 30% in Primary Progressive Multiple Sclerosis Patients from Phase 2 CALLIPER Trial ↗
Via Stocktwits
News headline image
Immunic to Participate in Scientific and Industry Conferences in May ↗
Via Stocktwits
Topics Economy
News headline image
Immunic, Inc. Announces Proposed Public Offering ↗
Via Stocktwits
Topics Regulatory Compliance
News headline image
Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering ↗
Via Stocktwits
News headline image
Immunic to Participate in Investor, Scientific and Industry Conferences in June ↗
Via Stocktwits
Topics Intellectual Property
News headline image
Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering ↗
Via Stocktwits
News headline image
Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS ↗
Via Stocktwits
News headline image
Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis ↗
Via Stocktwits
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Wednesday's session: top gainers and losers ↗
Intrigued by the market activity one hour before the close of the markets on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Wednesday's session: gap up and gap down stocks ↗
The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
These stocks that are showing activity before the opening bell on Wednesday. ↗
Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top gainers and losers in today's pre-market session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Immunic Stock Draws Investor Attention On $5.1M Registered Direct Offering: Retail’s On Wait-And-Watch Mode ↗
Immunic intends to use the net proceeds from the proposed offering to fund its clinical trials and operations and for other general corporate purposes. 
Via Stocktwits
Topics Intellectual Property Lawsuit
News headline image
Immunic to Present at the November 21st Virtual Investor Summit Microcap Event
Via ACCESSWIRE
News headline image
This Yelp Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday ↗
 
Via Benzinga
News headline image
Peek Behind the Curtain: 7 Penny Stocks With Heavy Insider Buying ↗
While speculative ideas are treacherous, you can possibly reduce your blood pressure with these penny stocks with insider buying. 
Via InvestorPlace
Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day
Immunic Inc (NASDAQ:IMUX) chief medical officer Dr Andreas Muehler discusses the importance of clinical trials in the biotech industry to mark Clinical Trials Day on May 20. 
Via TheNewswire.com
News headline image
Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day
Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day 
Via News Direct
News headline image
Immunic chief medical officer discusses promising treatments to mark World IBD Day
Immunic chief medical officer discusses promising treatments to mark World IBD Day 
Via News Direct
Immunic chief medical officer discusses promising treatments to mark World IBD Day
Immunic Inc (NASDAQ:IMUX) chief medical officer Dr Andreas Muehler discusses Inflammatory Bowel Disease (IBD) with Proactive's Stephen Gunnion to mark World IBD Day on May 19. 
Via TheNewswire.com
News headline image
Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day
Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day 
Via News Direct
Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day
Immunic Inc (NASDAQ:IMUX) chief scientific officer Hella Kohlhof joined Proactive's Stephen Gunnion on International Celiac Day, in the middle of Celiac Disease Awareness Month, to discuss the disease... 
Via TheNewswire.com
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.